DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Ellence (Epirubicin Hydrochloride) - Current Clinical Trials

 


Nutrilib.com
A comprihensive source of nutritional information

Ellence Related Clinical Trials

Adjuvant Epirubicin/Cytoxan Followed By A Taxane VS. Epirubicin/Taxane As Treatment For Node-Positive Breast Cancer [Terminated]

Study of Docetaxel in Breast Cancer Patients [Completed]

Epirubicin and Cyclophosphamide Compared With Epirubicin and Paclitaxel in Treating Women With Metastatic Breast Cancer [Active, not recruiting]

Preoperative Epirubicin Paclitaxel Aranesp Study (PREPARE) [Active, not recruiting]

Epirubicin and Docetaxel Combination (ET) or Epirubicin Followed by Docetaxel (E/T) for Node Negative (N0) High Risk Breast Cancer Patients [Recruiting]

Epirubicin and Docetaxel in the Treatment of Patients With Metastatic Breast Cancer [Terminated]

Cytoxan, Epirubicin and Capecitabine in Women With Breast Cancer [Active, not recruiting]

Study of Epirubicin (PharmorubicinŽ), Carboplatin (ParaplatinŽ) and Capecitabine (XelodaŽ) (ECC) in the Treatment of Unresectable Locally Advanced or Metastatic Gastric/Gastroesophageal Junction Cancer With Pharmacogenetic Correlates [Recruiting]

Phase II Study of Cisplatin Plus Epirubicin Salvage Chemo in Refractory Germ Cell Tumors [Terminated]

Dose-Dense Epirubicin and Cyclophosphamide (EC) Followed by Paclitaxel in Breast Cancer: Feasibility [Active, not recruiting]

Randomized Phase III Trial With Docetaxel Plus Epirubicine Versus Docetaxel Plus Capecitabine for Metastatic Breast Cancer [Completed]

Randomized Phase II Study of Epirubicin vs Caelyx in Pretreated Metastatic Breast Cancer [Recruiting]

Weekly Gemcitabine, Epirubicin, and Docetaxel in Locally Advanced or Inflammatory Breast Cancer [Active, not recruiting]

Phase I Trial of Valproic Acid and Epirubicin in Solid Tumor Malignancies [Recruiting]

Phase I Combination w/ Epirubicin [Recruiting]

A Study of Epirubicin With Estramustine Phosphate and Celecoxib for the Treatment of Prostate Cancer [Recruiting]

Epirubicin or Not in Patients With TOP2A (Topoisomerase (DNA) II Alpha (170kD)) Normal Early Breast Cancer [Recruiting]

Epirubicin and Celecoxib in Treating Patients With Hepatocellular Carcinoma [Active, not recruiting]

Docetaxel Followed by CEF (Cyclophosphamide, Epirubicin and 5-Fluorouracil) Compared to Docetaxel and Capecitabine Followed by CEX (Cyclophosphamide, Epirubicin and Capecitabine) as Adjuvant Treatment for Breast Cancer [Completed]

EC (Epirubicin, Cyclophosphamide) Followed by T (Docetaxel) Versus ET (Epirubicin, Docetaxel) Followed by X (Capecitabine) as Adjuvant Chemotherapy for Node Positive Operable Breast Cancer Patients [Completed]

Randomized Neoadjuvant Study of Epirubicin and Docetaxel With/Without Capecitabine in Early Breast Cancer [Recruiting]

Adjuvant Treatment of Breast Cancer With 1-3 Aflicted Lymph Nodes [Active, not recruiting]

Epirubicin and Tamoxifen With or Without Docetaxel in Treating Postmenopausal Women With Breast Cancer [Active, not recruiting]

Therapy With Bevacizumab (BEV), Epirubicin, and Cyclophosphamide Followed by Docetaxel Plus Trastuzumab and BEV Given as Neoadjuvant or Adjuvant Therapy for Women With Locally Advanced HER2 Positive Invasive Breast Cancer [Recruiting]

A Phase I, Open-Label, Study of Pazopanib in Combination With Epirubicin or Doxorubicin for Advanced Solid Tumors. [Recruiting]

Epirubicin and Thalidomide in Treating Patients With Liver Cancer [Completed]

Melanoma Epirubicin Sulindac Trial: Sulindac in Combination With Epirubicin in Patients With Advanced Melanoma [Recruiting]

Epirubicin in Treating Women Who Are Undergoing Surgery for Stage I, Stage II, or Stage III Breast Cancer [Suspended]

Study of Alimta and Epirubicin Administered in Patients With Locally Advanced or Metastatic Breast Cancer [Completed]

Epirubicin and Rituximab in Treating Patients With Relapsed or Refractory B-Cell Non-Hodgkin's Lymphoma or Chronic Lymphocytic Leukemia [Active, not recruiting]

A Study of Gemcitabine, Epirubicin, and Paclitaxel Combination Chemotherapy Given Before Surgery to Patients With Locally Advanced Breast Cancer [Completed]

Capecitabine, Epirubicin, and Carboplatin in Treating Patients With Progressive, Unresectable, or Metastatic Cancer [Recruiting]

Docetaxel/Epirubicin/Bevacizumab as First Line Therapy for Metastatic HER2 Negative Breast Cancer [Recruiting]

Neoadjuvant Chemotherapy of Primary Breast Cancer With Epirubicin/Docetaxel and Carboplatin/Docetaxel [Active, not recruiting]

Lapatinib and Epirubicin in Treating Patients With Metastatic Breast Cancer [Recruiting]

Gemcitabine/Cisplatin Vs Gemcitabine/Epirubicin for NSCLC [Recruiting]

Predictors for Response to Dose-Dense Docetaxel and Epirubicin Breast Cancer [Not yet recruiting]

Neoadjuvant Endostatin and Chemotherapy for Breast Cancer [Recruiting]

Epirubicin and Docetaxel in Treating Patients With Metastatic Prostate Cancer [Suspended]

Epirubicin, Docetaxel, and Capecitabine in Treating Women With Stage IIIA or Stage IIIB Breast Cancer [Active, not recruiting]

Dose Density FU 75 and FU 90 as Adjuvant Therapy for Early Breast Cancer [Completed]

Combination Chemotherapy With or Without Epirubicin in Treating Women With Stage I or Stage II Breast Cancer [Active, not recruiting]

Neoadjuvant or Adjuvant Epirubicin, Cyclophosphamide, and Paclitaxel in Treating Women With Stage I, Stage II, or Stage III Breast Cancer [Active, not recruiting]

Paclitaxel and Carboplatin With or Without Epirubicin in Treating Patients With Stage IIB, Stage III, or Stage IV Invasive Ovarian Epithelial, Fallopian Tube, or Peritoneal Cancer [Completed]

An Investigation of the Effect of the Promoter Polymorphism in the Glucuronosyltransferase 2B7 in Patients on Breast Cancer Treatment [No longer recruiting]

Epirubicin and Vinorelbine in Treating Patients With Stage II, Stage III, or Stage IV Breast Cancer [Recruiting]

Gemcitabine and Epirubicin in Treating Patients With Malignant Mesothelioma [Completed]

Sulindac and Epirubicin in Treating Patients With Metastatic Malignant Melanoma [Recruiting]

Epirubicin, Carboplatin, and Capecitabine in Treating Patients With Unresectable Locally Advanced, Metastatic, or Recurrent Solid Tumor

Phase I- Lapatinib and Epirubicin Study [Recruiting]

Docetaxel and Epirubicin With and Without G-CSF in Treating Women With Metastatic Breast Cancer

Neoadjuvant Epirubicin, Cyclophosphamide, and Paclitaxel With or Without Gemcitabine in Treating Women Who Are Undergoing Surgery for Early Breast Cancer

Neoadjuvant Chemotherapy + Herceptin in HER2 Positive Stage II-III Breast Cancer Patients [Recruiting]

Epirubicin Plus Irinotecan in Treating Patients With Advanced Cancer [Active, not recruiting]

Neo-Adjuvant Gemcitabine, Epirubicin, ABI-007 (GEA) in Locally Advanced or Inflammatory Breast Cancer [Active, not recruiting]

Epirubicin, Docetaxel, and Pegfilgrastim in Treating Women With Locally Advanced or Inflammatory Breast Cancer [Recruiting]

DPPE in Combination With Epirubicin and Cyclophosphamide in the Treatment of Breast Cancer

Epirubicin and Cyclophosphamide Followed By Docetaxel and Trastuzumab in Treating Women With HER2-Positive Stage III or Stage IV Breast Cancer [Recruiting]

Pharmacokinetic Study of Tesmilifene (YMB1002) Plus Epirubicin and Cyclophosphamide in Metastatic Breast Cancer [Active, not recruiting]

Topoisomerase II Alpha Gene Amplification and Protein Overexpression Predicting Efficacy of Epirubicin [Recruiting]

Docetaxel and Epirubicin in Advanced Gastric Cancer [Recruiting]

Pre-Operative Epirubicin, Cisplatin, and Capecitabine in Patients With Newly Diagnosed Localised Oesophageal Adenocarcinoma [Recruiting]

Docetaxel and Epirubicin as First-Line Therapy in Treating Patients With Locally Advanced or Metastatic Adenocarcinoma of the Stomach [No longer recruiting]

Combination Chemotherapy in Treating Patients With Extensive Stage Small Cell Lung Cancer [No longer recruiting]

Adjuvant Chemoradiation Therapy for Gastric or Gastroesophageal Junction Adenocarcinoma [No longer recruiting]

Phase II Study of Epirubicin, Cisplatin and Capecitabine (ECX) Versus Cisplatin and Capecitabine (CX) for Advanced Gastric Cancer (AGC) [Recruiting]

Doxorubicin or Epirubicin and Cyclophosphamide in Treating Older Women With Invasive Breast Cancer [Recruiting]

Combination Chemotherapy in Treating Women With Stage II or Stage III Breast Cancer [Active, not recruiting]

Combination Chemotherapy in Treating Women With Resected Breast Cancer [No longer recruiting]

Intravesical Epirubicin Plus BCG to Prevent the Recurrence of Transitional Cell Carcinoma of Bladder [Completed]

Epirubicin Cisplatin and FU Combined With Endostar in Patients With Advanced or Metastatic Gastric Cancer [Recruiting]

Continuous Infusion of FU Combined With Epirubicin and Oxaliplatin in Patients With A/MGC [Recruiting]

Docetaxel, Epirubicin, and Cyclophosphamide With or Without Trastuzumab in Treating Women With Locally Advanced Breast Cancer That Can Be Removed By Surgery [Recruiting]

Combination Chemotherapy Following Surgery in Treating Women With Early Stage Breast Cancer [No longer recruiting]

Neoadjuvant ECX Followed by Definitive Chemoradiation With/Without Surgery for Squamous Cell Carcinoma of the Oesophagus [Recruiting]

Combination Chemotherapy in Treating Women With Breast Cancer Who Have Undergone Surgery [No longer recruiting]

Perioperative Panitumumab and Epirubicin, Oxaliplatin and Xeloda (EOX) in Patients With Gastroesophageal Adenocarcinoma [Recruiting]

A Phase III Trials Program Exploring the Integration of Bevacizumab, Everolimus (RAD001), and Lapatinib Into Current Neoadjuvant Chemotherapy Regimes for Primary Breast Cancer [Recruiting]

AMG 102 Plus ECX for Unresectable Locally Advanced or Metastatic Gastric or Esophagogastric Junction Cancer [Recruiting]

Combination Chemotherapy, Surgery, and Radiation Therapy in Treating Patients With Locoregionally Advanced Cancer of the Esophagus, Gastroesophageal Junction, or Stomach [Recruiting]

Six vs 12 Months of Transtuzumab With Docetaxel Following FEC as Adjuvant Treatment in N+ Breast Cancer [Recruiting]

Phase II Neoadjuvant in Inflammatory Breast Cancer [Recruiting]

Lapatinib +/- Trastuzumab In Addition To Standard Neoadjuvant Breast Cancer Therapy. [Recruiting]

Investigating the Biological Effects of the Addition of Zoledronic Acid to Pre-Operative Chemotherapy in Breast Cancer [Recruiting]

Combination Chemotherapy in Treating Women With Stage I Breast Cancer [No longer recruiting]

Therapy With Abraxane and 5-Fluorouracil, Epirubicin, Cyclophosphamide (FEC) for Patients With Breast Cancer [Active, not recruiting]

Combination Chemotherapy Before Surgery in Treating Women With Breast Cancer [No longer recruiting]

Comparison of Three Combination Chemotherapy Regimens in Treating Women With Stage I or Stage II Breast Cancer [No longer recruiting]

Fluorouracil, Epirubicin, and Cyclophosphamide (FEC) Versus FEC Plus Paclitaxel as Adjuvant Treatment for Node Positive Breast Cancer Patients [Completed]

Combination Chemotherapy in Treating Patients With Metastatic Cancer of an Unknown Site of Origin [No longer recruiting]

Combination Chemotherapy in Treating Patients With Advanced Stomach Cancer [No longer recruiting]

Trial Exploring Feasibility of Densification and Optimal Sequencing of Postoperative Adjuvant Fluorouracil, Epirubicin Plus Cyclophosphamide (FEC) and Docetaxel Chemotherapy in Patients With High Risk Primary Operable Breast Cancer

High-Dose Combination Chemotherapy Plus Peripheral Stem Cell Transplantation Compared With Standard Combination Chemotherapy in Treating Women With High-Risk Breast Cancer [Active, not recruiting]

Docetaxel and Lapatinib With or Without Combination Chemotherapy or Docetaxel and Trastuzumab With Combination Chemotherapy in Treating Women With Locally Advanced, Inflammatory, or Resectable Breast Cancer [Recruiting]

Randomized Phase III Trial of Adjuvant Chemotherapy or Chemoradiotherapy in Resectable Gastric Cancer (CRITICS) [Recruiting]

A Randomized Study of Liposomal Doxorubicin in Women With Breast Cancer Exploiting Tissue Doppler Imaging [Recruiting]

Pre-Operative Chemotherapy Plus Bevacizumab With Early Salvage Therapy Based on PET Assessment of Response in Patients With Locally Advanced But Resectable Gastric and GEJ Adenocarcinoma [Recruiting]

Combination Chemotherapy and Paclitaxel Plus Trastuzumab in Treating Women With Palpable Breast Cancer That Can Be Removed by Surgery [Recruiting]

Combination Chemotherapy With or Without Capecitabine and/or Trastuzumab Before Surgery in Treating Women With Stage I, Stage II, or Stage III Breast Cancer [Recruiting]

A Feasibility Study to Evaluate Adjuvant Chemoradiotherapy for Gastric Cancer [Completed]

Combination Chemotherapy With or Without Fluorouracil and/or Pegfilgrastim in Treating Women With Node-Positive Breast Cancer [Active, not recruiting]

-- advertisement -- The American Red Cross

We comply with
HONcode standard.
Verify here.
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2008